Suggestions
Alice Pelton
Founder at The Lowdown I EF LD14 Cohort Member at Entrepreneur First
Alice Pelton is the Co-Founder and Chief Executive Officer of The Lowdown, a women's health technology company. The Lowdown provides a platform for women to review and rate their experiences with contraceptives and other reproductive health products and services.
As the CEO, Pelton leads the company's mission to improve women's health outcomes by leveraging user-generated data and reviews. She co-founded The Lowdown in 2019 after experiencing her own frustrations with contraceptive options and noticing a lack of reliable, user-driven information in this area.
Under Pelton's leadership, The Lowdown has grown to become a trusted resource for women seeking personalized contraceptive recommendations and health information. The platform allows users to share detailed reviews of birth control methods, helping other women make more informed decisions about their reproductive health.
Prior to founding The Lowdown, Pelton worked in product management and strategy roles at companies like Deliveroo and Babylon Health. Her background in technology and product development, combined with her passion for women's health, led her to create The Lowdown to address gaps she identified in reproductive health information and services.
Pelton is an advocate for improving women's healthcare through technology and data-driven approaches. She frequently speaks about femtech, women's health innovation, and entrepreneurship. Her work with The Lowdown aims to empower women with better information to take control of their reproductive health decisions.
Highlights
It’s a really exciting time for us at The Lowdown at the moment as we build our client facing partner offer. We’ve worked on some brilliant projects and now we’re looking for someone to help us build, grow and take it to the next level as a ⭐️ Business Development and Research Manager ⭐️
Click on the job link below if you are some combination of:
📈 Love sales, business development and the hustle of winning 👥 Have experience with client management and development 💊 Have worked in pharma and healthcare research 🔢 Are familiar with mixed methods of commercial research, with a leaning towards quant ❤️ Are passionate about making a difference in women’s health
For more information and how to apply, follow the link here:
I’m a bit bored of reading about the lack of funding female founders get, or the fact the Flo Health Inc. founders are male.
Here’s my take on why there aren't more European femtech unicorns like Flo 👇
👩⚖️ Regulation impacting growth: Prescription drugs can’t be advertised to consumers in Europe. You can’t bid on Google ad words, or talk about these products on social without breaking Meta’s guidelines. If you’re a D2C prescriptions company, this reduces your channels. And this regulation and shadow-banning seems to be worse in women’s health. Erectile dysfunction drugs like Viagra have been over the counter medications in the UK since 2017, whereas it took until 2021 to make the progestogen-only pill available without a prescription.
🆓 Commoditisation: Lots of tracking apps have struggled as the space quickly became commoditised. Flo found a way to put up a paywall at the right time and in the right place in the product. Other digital therapeutics have struggled to make the premium side of the product worth paying for.
🚚 Does the nature of women's health conditions lead to less accessible privatisation? Lots of men don’t want to tell their GP about erectile dysfunction and would clearly rather go online. Many of our women's health conditions like endometriosis and PCOS are not diagnosed remotely, or managed by sending a pill through the post.
💰 The NHS won’t pay: FYI the Women’s Health Hubs are virtual, not real hubs. From speaking with people inside the NHS, the £25m budget allocated to them has already been slashed. Is anyone in the public sector spending on digital health solutions for women? And just monetising via the NHS is not going to be a big enough market to build a unicorn, obviously.
🌊 We’re still in the first wave, with few second time femtech founders. Entrepreneurs with a past successful venture have a 30% chance of success in their next endeavour, compared to an 18% chance for newcomers and a 20% chance for those with prior failures. Experience counts.
🏥 The VC funding market has crashed, and digital health in general is taking a dip in funding and sexiness: Lots of generalist investors piled into this sector around COVID in 2021, and have gradually pulled out. It's not all about lack of funding for female founders, but funding in general.
💊 On the B2B side, less pharma and life sciences investment has a trickle down effect: Less women’s health focussed therapeutics = less research = less CROs = less money sloshing around to build B2B businesses, agencies and capabilities from.
What do you think the reasons are? Comment below, I’m genuinely interested to hear everyone’s thoughts 👇
